Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
Unlock unbeatable offers today. Shop here: https://amzn.to/4cEkqYs 🎁
Profits are bad. The best new drugs come from unprofitable drug companies.
Look at all the great drugs developed in Cuba and Venezuela.
All drugs should be free.
Did I miss any? LOL!
here you go you ignorant rubeProfits are bad. The best new drugs come from unprofitable drug companies.
Look at all the great drugs developed in Cuba and Venezuela.
All drugs should be free.
Did I miss any? LOL!
Bringing Cuba’s Lung Cancer Vaccine to the States
Bringing Cuba’s Lung Cancer Vaccine to the States
Most people would be quite surprised to learn that there is a vaccine for lung cancer, one which has been proven effective in over 25 years of intense research and several years of clinical use. So why is most of the world only learning about it now? The answer is complicated by back-room dealings in the dark recesses of government, and by the unhealthy influence that pharmaceutical companies have on the availability of life-saving medications.
Cuba has faced many public health issues over the last few decades, one of the gravest being related the country’s most famous export, tobacco. A rise in cases of lung cancer prompted this small nation to develop a drug called CimaVax EGF, which is now one of the most effective medications in existence to treat lung cancer.
Cuba Develops Four Cancer Vaccines, Ignored by the Media
Wow! Cuba has a potential drug? Excellent news!
That makes up for enslaving the island for 50+ years.
Stupid git.
Tell you what. You invest $500 million into a new drug and wait 10 years to see if it gets approved. If it does get approved you can then give them away for free.Drugmakers ring in 2016 with hefty price hikes
"Drugmakers including Pfizer (PFE) and Allergan (AGN) have boosted prices on many brand-name medications since last month. The price hikes, ranging from 1.3 percent to 42.3 percent, reflect the list prices, which don't represent the discounts and rebates negotiated by insurers and health care providers."
"Since Jan. 1, Pfizer has boosted the list prices of dozens of drugs, with the average increase set at 10.6 percent, according to a new report from Deutsche Bank. Even though it's common practice for drugmakers to lift prices at the start of each year, the pharmaceutical industry is increasingly under the spotlight for what some lawmakers and patients allege amounts to price gouging."
"
Pfizer Inc. reported second-quarter earnings that beat analysts’ estimates and raised its full-year profit forecast as sales of a new cancer drug climbed.
Adjusted earnings of 56 cents a share topped the average projection of 52 cents, according to data compiled by Bloomberg. First-quarter sales of $11.9 billion compared with analysts’ projection of $11.4 billion.
The drug Ibrance, approved in February by U.S. regulators for use in advanced breast cancer, generated $140 million in sales, compared with the $95.3 million projected by analysts. Ibrance will be a $3.39 billion drug by 2018, according to analysts’ estimates. Total oncology sales, including drugs such as Sutent, Inlyta and Xalkori, rose 25 percent from a year earlier."
Pfizer Profit Beats Estimates as Cancer Drug Sales Increase
Tell you what. You invest $500 million into a new drug and wait 10 years to see if it gets approved. If it does get approved you can then give them away for free.Drugmakers ring in 2016 with hefty price hikes
"Drugmakers including Pfizer (PFE) and Allergan (AGN) have boosted prices on many brand-name medications since last month. The price hikes, ranging from 1.3 percent to 42.3 percent, reflect the list prices, which don't represent the discounts and rebates negotiated by insurers and health care providers."
"Since Jan. 1, Pfizer has boosted the list prices of dozens of drugs, with the average increase set at 10.6 percent, according to a new report from Deutsche Bank. Even though it's common practice for drugmakers to lift prices at the start of each year, the pharmaceutical industry is increasingly under the spotlight for what some lawmakers and patients allege amounts to price gouging."
"
Pfizer Inc. reported second-quarter earnings that beat analysts’ estimates and raised its full-year profit forecast as sales of a new cancer drug climbed.
Adjusted earnings of 56 cents a share topped the average projection of 52 cents, according to data compiled by Bloomberg. First-quarter sales of $11.9 billion compared with analysts’ projection of $11.4 billion.
The drug Ibrance, approved in February by U.S. regulators for use in advanced breast cancer, generated $140 million in sales, compared with the $95.3 million projected by analysts. Ibrance will be a $3.39 billion drug by 2018, according to analysts’ estimates. Total oncology sales, including drugs such as Sutent, Inlyta and Xalkori, rose 25 percent from a year earlier."
Pfizer Profit Beats Estimates as Cancer Drug Sales Increase
How utterly ridiculous can you be. There is no mention of profit being bad but price gouging with the health of others seems to be totally fine with you.
Which makes you as bad as the profiteers.
Profits are bad. The best new drugs come from unprofitable drug companies.
Look at all the great drugs developed in Cuba and Venezuela.
All drugs should be free.
Did I miss any? LOL!
Look at the profits they have made of the past 20 yrs. then get back to us and tell us how they are so utterly ruined by waiting.
Look at the profits they have made of the past 20 yrs. then get back to us and tell us how they are so utterly ruined by waiting.
They also stopped research on a lot of drugs due to FDA delays and waiting....
People gambling with $500M for 10 years expect a payoff.Look at the profits they have made of the past 20 yrs. then get back to us and tell us how they are so utterly ruined by waiting.
Tell you what. You invest $500 million into a new drug and wait 10 years to see if it gets approved. If it does get approved you can then give them away for free.Drugmakers ring in 2016 with hefty price hikes
"Drugmakers including Pfizer (PFE) and Allergan (AGN) have boosted prices on many brand-name medications since last month. The price hikes, ranging from 1.3 percent to 42.3 percent, reflect the list prices, which don't represent the discounts and rebates negotiated by insurers and health care providers."
"Since Jan. 1, Pfizer has boosted the list prices of dozens of drugs, with the average increase set at 10.6 percent, according to a new report from Deutsche Bank. Even though it's common practice for drugmakers to lift prices at the start of each year, the pharmaceutical industry is increasingly under the spotlight for what some lawmakers and patients allege amounts to price gouging."
"
Pfizer Inc. reported second-quarter earnings that beat analysts’ estimates and raised its full-year profit forecast as sales of a new cancer drug climbed.
Adjusted earnings of 56 cents a share topped the average projection of 52 cents, according to data compiled by Bloomberg. First-quarter sales of $11.9 billion compared with analysts’ projection of $11.4 billion.
The drug Ibrance, approved in February by U.S. regulators for use in advanced breast cancer, generated $140 million in sales, compared with the $95.3 million projected by analysts. Ibrance will be a $3.39 billion drug by 2018, according to analysts’ estimates. Total oncology sales, including drugs such as Sutent, Inlyta and Xalkori, rose 25 percent from a year earlier."
Pfizer Profit Beats Estimates as Cancer Drug Sales Increase
People gambling with $500M for 10 years expect a payoff.Look at the profits they have made of the past 20 yrs. then get back to us and tell us how they are so utterly ruined by waiting.
Tell you what. You invest $500 million into a new drug and wait 10 years to see if it gets approved. If it does get approved you can then give them away for free.Drugmakers ring in 2016 with hefty price hikes
"Drugmakers including Pfizer (PFE) and Allergan (AGN) have boosted prices on many brand-name medications since last month. The price hikes, ranging from 1.3 percent to 42.3 percent, reflect the list prices, which don't represent the discounts and rebates negotiated by insurers and health care providers."
"Since Jan. 1, Pfizer has boosted the list prices of dozens of drugs, with the average increase set at 10.6 percent, according to a new report from Deutsche Bank. Even though it's common practice for drugmakers to lift prices at the start of each year, the pharmaceutical industry is increasingly under the spotlight for what some lawmakers and patients allege amounts to price gouging."
"
Pfizer Inc. reported second-quarter earnings that beat analysts’ estimates and raised its full-year profit forecast as sales of a new cancer drug climbed.
Adjusted earnings of 56 cents a share topped the average projection of 52 cents, according to data compiled by Bloomberg. First-quarter sales of $11.9 billion compared with analysts’ projection of $11.4 billion.
The drug Ibrance, approved in February by U.S. regulators for use in advanced breast cancer, generated $140 million in sales, compared with the $95.3 million projected by analysts. Ibrance will be a $3.39 billion drug by 2018, according to analysts’ estimates. Total oncology sales, including drugs such as Sutent, Inlyta and Xalkori, rose 25 percent from a year earlier."
Pfizer Profit Beats Estimates as Cancer Drug Sales Increase
But like I said, it's a free country and you should get all your fellow leftists together and raise $500M so in the small chance the new drug gets approved in 10 years you can give it away.
Yes, but their strangle hold on Congress with multiple lobbyists for each member of Congress. They get what they want, so they can do what they want. If their industry was in trouble it would have reared its ugly head long ago. But..............it isn't.
Another step toward single payer.
They, the pharmaceutical companies wont let drugs from other countries make its way into our country?
WHY?
They are playing god and using the system to gain favor.
Yes, but their strangle hold on Congress with multiple lobbyists for each member of Congress. They get what they want, so they can do what they want. If their industry was in trouble it would have reared its ugly head long ago. But..............it isn't.
Not many big American pharmaceutical companies any more. You sure about that statement?
They, the pharmaceutical companies wont let drugs from other countries make its way into our country?
WHY?
They are playing god and using the system to gain favor.
We might have to hire a full time myth buster for you.
People gambling with $500M for 10 years expect a payoff.Look at the profits they have made of the past 20 yrs. then get back to us and tell us how they are so utterly ruined by waiting.
Tell you what. You invest $500 million into a new drug and wait 10 years to see if it gets approved. If it does get approved you can then give them away for free.Drugmakers ring in 2016 with hefty price hikes
"Drugmakers including Pfizer (PFE) and Allergan (AGN) have boosted prices on many brand-name medications since last month. The price hikes, ranging from 1.3 percent to 42.3 percent, reflect the list prices, which don't represent the discounts and rebates negotiated by insurers and health care providers."
"Since Jan. 1, Pfizer has boosted the list prices of dozens of drugs, with the average increase set at 10.6 percent, according to a new report from Deutsche Bank. Even though it's common practice for drugmakers to lift prices at the start of each year, the pharmaceutical industry is increasingly under the spotlight for what some lawmakers and patients allege amounts to price gouging."
"
Pfizer Inc. reported second-quarter earnings that beat analysts’ estimates and raised its full-year profit forecast as sales of a new cancer drug climbed.
Adjusted earnings of 56 cents a share topped the average projection of 52 cents, according to data compiled by Bloomberg. First-quarter sales of $11.9 billion compared with analysts’ projection of $11.4 billion.
The drug Ibrance, approved in February by U.S. regulators for use in advanced breast cancer, generated $140 million in sales, compared with the $95.3 million projected by analysts. Ibrance will be a $3.39 billion drug by 2018, according to analysts’ estimates. Total oncology sales, including drugs such as Sutent, Inlyta and Xalkori, rose 25 percent from a year earlier."
Pfizer Profit Beats Estimates as Cancer Drug Sales Increase
Private companies make import laws now?They, the pharmaceutical companies wont let drugs from other countries make its way into our country?
WHY?
They are playing god and using the system to gain favor.
People gambling with $500M for 10 years expect a payoff.Look at the profits they have made of the past 20 yrs. then get back to us and tell us how they are so utterly ruined by waiting.
Tell you what. You invest $500 million into a new drug and wait 10 years to see if it gets approved. If it does get approved you can then give them away for free.Drugmakers ring in 2016 with hefty price hikes
"Drugmakers including Pfizer (PFE) and Allergan (AGN) have boosted prices on many brand-name medications since last month. The price hikes, ranging from 1.3 percent to 42.3 percent, reflect the list prices, which don't represent the discounts and rebates negotiated by insurers and health care providers."
"Since Jan. 1, Pfizer has boosted the list prices of dozens of drugs, with the average increase set at 10.6 percent, according to a new report from Deutsche Bank. Even though it's common practice for drugmakers to lift prices at the start of each year, the pharmaceutical industry is increasingly under the spotlight for what some lawmakers and patients allege amounts to price gouging."
"
Pfizer Inc. reported second-quarter earnings that beat analysts’ estimates and raised its full-year profit forecast as sales of a new cancer drug climbed.
Adjusted earnings of 56 cents a share topped the average projection of 52 cents, according to data compiled by Bloomberg. First-quarter sales of $11.9 billion compared with analysts’ projection of $11.4 billion.
The drug Ibrance, approved in February by U.S. regulators for use in advanced breast cancer, generated $140 million in sales, compared with the $95.3 million projected by analysts. Ibrance will be a $3.39 billion drug by 2018, according to analysts’ estimates. Total oncology sales, including drugs such as Sutent, Inlyta and Xalkori, rose 25 percent from a year earlier."
Pfizer Profit Beats Estimates as Cancer Drug Sales Increase
But like I said, it's a free country and you should get all your fellow leftists together and raise $500M so in the small chance the new drug gets approved in 10 years you can give it away.
You could revise copays too. If you actually required treatment, then the copay stands, If you did not need treatment, then you pay a double copay.
here you go you ignorant rubeProfits are bad. The best new drugs come from unprofitable drug companies.
Look at all the great drugs developed in Cuba and Venezuela.
All drugs should be free.
Did I miss any? LOL!
Bringing Cuba’s Lung Cancer Vaccine to the States
Bringing Cuba’s Lung Cancer Vaccine to the States
Most people would be quite surprised to learn that there is a vaccine for lung cancer, one which has been proven effective in over 25 years of intense research and several years of clinical use. So why is most of the world only learning about it now? The answer is complicated by back-room dealings in the dark recesses of government, and by the unhealthy influence that pharmaceutical companies have on the availability of life-saving medications.
Cuba has faced many public health issues over the last few decades, one of the gravest being related the country’s most famous export, tobacco. A rise in cases of lung cancer prompted this small nation to develop a drug called CimaVax EGF, which is now one of the most effective medications in existence to treat lung cancer.
Cuba Develops Four Cancer Vaccines, Ignored by the Media
Wow! Cuba has a potential drug? Excellent news!
That makes up for enslaving the island for 50+ years.
Stupid git.
Well, you abandoned your previous point with the quickness. Thats what happens when you speak on shit you know nothing about.
You never said they have to develop a drug that makes up for enslaving anything. Since drugs dont work that way....you're stupid
Well, you abandoned your previous point with the quickness.
The point that profit is a good and necessary part of progress?
Sorry, not abandoned at all.
I'll put the profitable results of US research up against the entire world, not just the failure that sits off the coast of Florida.
Time to play stupid huh? You said Cuba didnt develop drugs then when you were shown you were wrong you changed it into only Cuban drugs has to make up for injustices. The quickest 180 ever seen
How utterly ridiculous can you be. There is no mention of profit being bad but price gouging with the health of others seems to be totally fine with you.
Which makes you as bad as the profiteers.
Profits are bad. The best new drugs come from unprofitable drug companies.
Look at all the great drugs developed in Cuba and Venezuela.
All drugs should be free.
Did I miss any? LOL!
